Medical Device Reprocessing Market Report 2025

The medical device reprocessing market size has grown rapidly in recent years. It will grow from $2.43 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to cost containment pressures, regulatory evolution, increased environmental awareness, demand for single-use device alternatives, hand hospital budget constraints.

The medical device reprocessing market size is expected to see rapid growth in the next few years. It will grow to $5.08 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to rising demand for sustainable practices, global healthcare spending patterns, increasing focus on value-based care, expansion in emerging markets, consumer confidence, and acceptance. Major trends in the forecast period include advanced disinfection techniques, sustainable packaging and material innovation, circular economy initiatives, hybrid reprocessing models, focus on remote reprocessing technologies.

An anticipated rise in surgical procedures is expected to drive the growth of the medical device reprocessing market in the coming years. Surgical procedures involve medical interventions that require incisions and the use of instruments to treat or repair diseases within a living body. Reprocessing entails the cleaning of equipment by removing blood, tissue, and other biological contaminants, as well as inactivating infectious microorganisms to ensure the tools are safe for the next patient. For instance, in February 2024, the National Healthcare Statistics, a U.S.-based government agency, reported that cataract surgery was the most frequently performed surgical procedure in 2022, with a total of 39,347 cases, of which 98.3% were conducted as outpatient procedures. This was followed by 20,537 caesarean sections and 12,830 hip replacements, nearly all of which were inpatient procedures. Consequently, the increase in surgical procedures is driving the growth of the medical device reprocessing market.

The rising prevalence of chronic diseases is expected to contribute significantly to the growth of the medical device reprocessing market. Chronic diseases, characterized by long-term conditions that require ongoing medical attention and can limit daily activities, often lead to substantial healthcare costs. Reprocessing medical devices instead of discarding them after each use presents a cost-effective solution for both patients and healthcare institutions. For instance, in 2022, the Centers for Disease Control and Prevention reported that diabetes affects approximately 37.3 million Americans or 11.3% of the population. Moreover, in July 2022, the same organization highlighted that six out of ten adults in the U.S. have chronic diseases, with four out of ten adults suffering from more than two chronic conditions such as chronic lung disease, heart disease, stroke, and diabetes. Therefore, the rising prevalence of chronic diseases is identified as a significant factor driving the growth of the medical device reprocessing market.

Technological advancements emerge as a prominent trend gaining traction in the medical device reprocessing market, with major companies strategically adopting new technologies to maintain their positions. For example, in June 2022, Getinge, a Sweden-based medical technology company, launched an updated version of its endoscope washer-disinfector, the ED-Flow automated endoscope reprocessor. This innovation offers customers enhanced digital connectivity and data management, leading to increased uptime and productivity. The ED-Flow utilizes traceability software, T-DOC, efficiently handling flexible endoscope leak testing, cleaning, and high-level disinfection, delivering practical and reliable outcomes.

Major players in the medical device reprocessing market are focusing on strategic partnerships to enhance their market presence. For instance, in October 2023, the partnership between AA Medical, a US-based provider of sustainable solutions for medical devices, and Tekyard, a US-based healthcare asset management company, along with Zantek Medical, a US-based biomed medical device reprocessing company. This collaboration is expected to accelerate AA Medical's long-term growth plan and contribute to its goal of becoming the premier technology-driven medical equipment platform in the United States.

In October 2023, Getinge AB, a medical technology company based in Sweden, completed the acquisition of Healthmark Industries Co. Inc. for an undisclosed amount. This acquisition is intended to strengthen Getinge's infection control portfolio by incorporating Healthmark’s expertise in innovative cleaning and packaging solutions designed for healthcare providers. Healthmark Industries, a U.S.-based company, focuses on the development and manufacturing of products aimed at the cleaning, testing, and validation of medical devices.

Major companies operating in the medical device reprocessing market include Cardinal Health, Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic PLC, Danaher Corporation, Fresenius Medical Care, Medline Industries Inc., Stryker Corporation, GE Healthcare, Boston Scientific, Fujifilm Medical Systems, Zimmer Biomet, Olympus Corporation, Intuitive Surgical, Hologic, STERIS Healthcare, Getinge AB, Teleflex Inc., Centurion Medical Inc., Vanguard AG, SteriPro, Medivators Inc., Hygia Healthcare LLC, Innovative Health, LUMITOS AG, SureTek Medical, 3M Health Care, ArjoHuntleigh, Northeast Scientific.

North America was the largest region in the medical device reprocessing market in 2024. Europe is expected to be the fastest-growing region in the medical device reprocessing market report during the forecast period. The regions covered in the medical device reprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device reprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medical device reprocessing involves the procedure of safely preparing and reusing used medical devices for subsequent patients. This process is typically carried out by specialized healthcare facilities or companies equipped with the necessary tools, expertise, and protocols to ensure the proper cleaning and sterilization of these devices.

There are two main types of medical device reprocessing, reprocessing support and services, and reprocessing medical devices. Reprocessing support and services encompass the assistance and resources provided to healthcare facilities or companies engaged in the reprocessing of medical devices. The device categories involved in this process are critical devices, semi-critical devices, and non-critical devices. These devices find applications in various medical fields, including cardiology, gastroenterology, gynecology, orthopedics, general surgery, and others. They are utilized by different end-users such as hospitals, ambulatory service centers, and home healthcare.

The medical device reprocessing market research report is one of a series of new reports that provides medical device reprocessing market statistics, including medical device reprocessing industry global market size, regional shares, competitors with a medical device reprocessing market share, detailed medical device reprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reprocessing industry. This medical device reprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. 

The medical device reprocessing market consists of revenues earned by entities by providing sterilizing, disinfecting, as well as evaluation and restoration of the used devices. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device reprocessing market also includes sales of surgical forceps, endoscopes, stethoscopes, catheters, and laryngoscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.